000 04928naa a22005417i 4500
001 UMUN-OA-20261005-MLS-044
003 local
005 20261005174905.0
006 m o d
007 cr||||||||||||
008 261005s2020 xx o u000 0 eng d
024 7 _a10.3389/fcell.2020.00360
_2doi
035 _a(local)EuropePMC:PMC7264387
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aGrace C Limandjaja
_eauthor.
245 1 4 _aThe Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models. /
_cGrace C Limandjaja; Frank B Niessen; Rik J Scheper [and others].
264 1 _a[Place of publication not identified] :
_bFrontiers Media SA,
_c2020.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aKeloids constitute an abnormal fibroproliferative wound healing response in which raised scar tissue grows excessively and invasively beyond the original wound borders. This review provides a comprehensive overview of several important themes in keloid research: namely keloid histopathology, heterogeneity, pathogenesis, and model systems. Although keloidal collagen versus nodules and α-SMA-immunoreactivity have been considered pathognomonic for keloids versus hypertrophic scars, conflicting results have been reported which will be discussed together with other histopathological keloid characteristics. Importantly, histopathological keloid abnormalities are also present in the keloid epidermis. Heterogeneity between and within keloids exists which is often not considered when interpreting results and may explain discrepancies between studies. At least two distinct keloid phenotypes exist, the superficial-spreading/flat keloids and the bulging/raised keloids. Within keloids, the periphery is often seen as the actively growing margin compared to the more quiescent center, although the opposite has also been reported. Interestingly, the normal skin directly surrounding keloids also shows partial keloid characteristics. Keloids are most likely to occur after an inciting stimulus such as (minor and disproportionate) dermal injury or an inflammatory process (environmental factors) at a keloid-prone anatomical site (topological factors) in a genetically predisposed individual (patient-related factors). The specific cellular abnormalities these various patient, topological and environmental factors generate to ultimately result in keloid scar formation are discussed. Existing keloid models can largely be divided into in vivo and in vitro systems including a number of subdivisions: human/animal, explant/culture, homotypic/heterotypic culture, direct/indirect co-culture, and 3D/monolayer culture. As skin physiology, immunology and wound healing is markedly different in animals and since keloids are exclusive to humans, there is a need for relevant human in vitro models. Of these, the direct co-culture systems that generate full thickness keloid equivalents appear the most promising and will be key to further advance keloid research on its pathogenesis and thereby ultimately advance keloid treatment. Finally, the recent change in keloid nomenclature will be discussed, which has moved away from identifying keloids solely as abnormal scars with a purely cosmetic association toward understanding keloids for the fibroproliferative disorder that they are.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aKeloid
650 4 _aCicatrix, Hypertrophic
650 4 _aKeloid Anatomy And Histology
650 4 _aKeloid Etiology
650 4 _aKeloid Pathology
650 4 _aKeloid Heterogeneity
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _ahistopathology
655 4 _aReview articles.
700 0 _aFrank B Niessen
_eauthor.
700 0 _aRik J Scheper
_eauthor.
700 0 _aSusan Gibbs
_eauthor.
773 0 _tFrontiers in cell and developmental biology
_gVol. 8, (2020), pages/article 360
_x2296-634X
856 4 0 _uhttps://europepmc.org/articles/PMC7264387
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC7264387
_qlocal
942 _n0
999 _c1186
_d1186